| 100.57 |  -2.10 / -2.05% |
Data as of 4:00pm ET | Day’s Change |
| 100.57 |  0.00 / 0.00% |
Volume: 15.2K |
| Bayer Files Riociguat in Japan - Analyst Blog May 21 / Zacks.com | Bayer's Xofigo Cleared in the US - Analyst Blog May 16 / Zacks.com |
| Yet Another Acquisition for Bayer - Analyst Blog May 21 / Zacks.com | Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Drugs Laggard May 16 / TheStreet.com |
| 5 Stocks Underperforming Today In The Drugs Industry May 20 / TheStreet.com | 3 Stocks Underperforming Today In The Drugs Industry May 15 / TheStreet.com |
| Biogen's Hemophilia BLA Accepted - Analyst Blog May 20 / Zacks.com | Shire - rarity value May 03 / FT.com |
| Previous close | 102.67 |
| Today’s open | 103.00 |
| Day’s range | 99.35 - 104.50 |
| Volume | 1,131,564 |
| Average volume (3 months) | 1,669,238 |
| Market cap | $20.0B |
| Dividend yield | -- |
| Earnings growth (last year) | +40.66% |
| Earnings growth (this year) | +38.62% |
| Earnings growth (next 5 years) | +23.60% |
| Revenue growth (last year) | +41.93% |
| P/E ratio | 69.4 |
| Price/Sales | 15.92 |
| Price/Book | 10.14 |
| Today’s change | Today’s % change | |
|---|---|---|
| SHPGShire PLC | +0.10 | +0.10% |
| VRTXVertex Pharmaceutica... | -1.04 | -1.31% |
| ACTActavis Inc | -0.16 | -0.12% |
| VRXValeant Pharmaceutic... | -0.71 | -0.94% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.68 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $254.8M |
| Net profit margin | 22.73% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer, Treasurer & Director Leonard Bell, MD |
Chief Global Operations Officer & Executive VP Stephen P. Squinto, PhD |
Corporate headquarters Cheshire, Connecticut |
.
